David Livingston/Getty Images Since going public along with his Stage 3 non-Hodgkin lymphoma evaluation in November 2024, Dave Coulier has been candid about his sickness, treatment and prognosis. Non-Hodgkin lymphoma is a form of cancer that is affecting the affected person’s lymphatic system, with “white blood cells known as lymphocytes [that] grow abnormally and can invent growths (tumors) in the route of[…[…
Be taught Extra
